[Effect of neuroleptoanalgesia, type II (NLA II) on the course of experimental and clinical hyperthyroidism. II. Effects of NLA II on the oxygen metabolism of the brain stem, heart, liver and kidney in experimental hyperthyroidism].
D000818:Animals; D001544:Benperidol / Q000494:pharmacology / Q000627:therapeutic use*; D001933:Brain Stem / Q000378:metabolism*; D005260:Female; D005283:Fentanyl / Q000494:pharmacology / Q000627:therapeutic use*; D006980:Hyperthyroidism / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009458:Neuroleptanalgesia; D010101:Oxygen Consumption; D011817:Rabbits; D013958:Thyroid Crisis / Q000188:drug therapy*; D013997:Time Factors
D001544:Benperidol; D005283:Fentanyl
Wpływ neuroleptanalgezji typu II (NLA II) na przebieg doświadczalnej i klinicznej nadczynności tarczycy. II. Wpływ NLA II na metabolizm tlenowy pnia mózgu, serca, watroby i nerki w doświadczalnej nadczynności tarczycy.